Showing results (11-20 of 175) with videos related to
Sort By:
Pageof 18
Cancer Research|June 4, 2009
Effects of vandetanib on lung adenocarcinoma cells harboring epidermal growth factor receptor T790M mutation in vivoEiki Ichihara, Kadoaki Ohashi, Nagio Takigawa, et al.Japanese Journal of Clinical Oncology|February 5, 2008
Pseudoprogression of lung cancer after concomitant chemoradiotherapyEiki Ichihara, Katsuyuki Kiura, Nagio Takigawa, et al.Acta Medica Okayama|October 27, 2020
Rapid Disease Progression of Advanced Non-small Cell Lung Cancer Five Months after Cessation of PembrolizumabAtsuko Hirabae, Eiki Ichihara, Ryota Sunami, et al.Internal Medicine (Tokyo, Japan)|August 21, 2022
Anti-SOX1 Antibody-positive Small-cell Lung Cancer That Triggered OpsoclonusYuki Chiko, Yuka Sugisaki, Keiji Miyoshi, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 15, 2025
Cancer-related alopecia and wig acquisition: how age, sex, and treatment affect patient choicesHideki Katayama, Eiki Ichihara, Ayako Morita, et al.In Vivo (Athens, Greece)|October 31, 2019
Granulation Tissue-induced Pseudo-relapse During Nivolumab Treatment in Advanced Non-small Cell Lung CancerChihiro Ando, Eiki Ichihara, Hirohisa Kano, et al.Lung Cancer (Amsterdam, Netherlands)|August 4, 2012
Influence of the timing of tumor regression after the initiation of chemoradiotherapy on prognosis in patients with limited-disease small-cell lung cancer achieving objective responseMasanori Fujii, Katsuyuki Hotta, Nagio Takigawa, et al.Plos One|November 25, 2011
Role of survival post-progression in phase III trials of systemic chemotherapy in advanced non-small-cell lung cancer: a systematic reviewKatsuyuki Hotta, Katsuyuki Kiura, Yoshiro Fujiwara, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 21, 2007
[Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult]Toshio Kubo, Nagio Takigawa, Yasushi Tanimoto, et al.Oncotarget|July 24, 2018
Clinical significance of repeat rebiopsy in detecting the EGFR T790M secondary mutation in patients with non-small cell lung cancerEiki Ichihara, Katsuyuki Hotta, Toshio Kubo, et al.Pageof 18